{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:48:52Z","timestamp":1745840932053,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL007915"],"award-info":[{"award-number":["T32-HL007915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00246-023-03163-4","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T11:02:08Z","timestamp":1683284528000},"page":"1415-1423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improvement in Palivizumab Administration Prior to Discharge for Hospitalized Infants with Hemodynamically Significant Congenital Heart Disease: A Quality Improvement Initiative"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-5497","authenticated-orcid":false,"given":"Andrea L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Neubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Hager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailey","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan Zachary","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Schachtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobha","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"3163_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/infdis\/jiaa751","volume":"226","author":"T Shi","year":"2021","unstructured":"Shi T et al (2021) Risk factors for RSV associated acute lower respiratory infection poor outcome and mortality in young children: a systematic review and meta-analysis. J Infect Dis 226:S10\u2013S16","journal-title":"J Infect Dis"},{"issue":"6","key":"3163_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall CB et al (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360(6):588\u2013598","journal-title":"N Engl J Med"},{"issue":"2","key":"3163_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/HCO.0b013e32835dce2f","volume":"28","author":"B Resch","year":"2013","unstructured":"Resch B, Michel-Behnke I (2013) Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab. Curr Opin Cardiol 28(2):85\u201391","journal-title":"Curr Opin Cardiol"},{"issue":"12","key":"3163_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00431-007-0426-y","volume":"166","author":"A Simon","year":"2007","unstructured":"Simon A et al (2007) Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database. Eur J Pediatr 166(12):1273\u20131283","journal-title":"Eur J Pediatr"},{"issue":"2","key":"3163_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40121-014-0046-6","volume":"3","author":"C Wegzyn","year":"2014","unstructured":"Wegzyn C et al (2014) Safety and effectiveness of palivizumab in children at high risk of serious disease due to respiratory syncytial virus infection: a systematic review. Infect Dis Ther 3(2):133\u2013158","journal-title":"Infect Dis Ther"},{"issue":"4","key":"3163_CR6","first-page":"CD006602","volume":"8","author":"T Andabaka","year":"2013","unstructured":"Andabaka T et al (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 8(4):CD006602","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3163_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","volume":"134","author":"American Academy of Pediatrics Committee on Infectious, D. and C. American Academy of Pediatrics Bronchiolitis Guidelines","year":"2014","unstructured":"American Academy of Pediatrics Committee on Infectious, D. and C. American Academy of Pediatrics Bronchiolitis Guidelines (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415\u2013420","journal-title":"Pediatrics"},{"issue":"1","key":"3163_CR8","first-page":"46","volume":"16","author":"MP Frogel","year":"2010","unstructured":"Frogel MP et al (2010) A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis. J Manag Care Pharm 16(1):46\u201358","journal-title":"J Manag Care Pharm"},{"issue":"10","key":"3163_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/INF.0b013e318174e0c4","volume":"27","author":"M Frogel","year":"2008","unstructured":"Frogel M et al (2008) Improved outcomes with home-based administration of palivizumab: results from the 2000\u20132004 Palivizumab Outcomes Registry. Pediatr Infect Dis J 27(10):870\u2013873","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"3163_CR10","first-page":"58","volume":"24","author":"NM Rida","year":"2019","unstructured":"Rida NM, Tribble A, Klein KC (2019) Implementation of a palivizumab order panel to decrease inappropriate use. J Pediatr Pharmacol Ther 24(1):58\u201360","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"3163_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4338\/ACI-2015-08-RA-0096","volume":"6","author":"LH Utidjian","year":"2015","unstructured":"Utidjian LH et al (2015) Clinical decision support and palivizumab: a means to protect from respiratory syncytial virus. Appl Clin Inform 6(4):769\u2013784","journal-title":"Appl Clin Inform"},{"issue":"5","key":"3163_CR12","first-page":"338","volume":"22","author":"JW Chow","year":"2017","unstructured":"Chow JW et al (2017) Improving palivizumab compliance rough a pharmacist-managed RSV prevention clinic. J Pediatr Pharmacol Ther 22(5):338\u2013343","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"7","key":"3163_CR13","first-page":"636","volume":"25","author":"KL Weaver","year":"2020","unstructured":"Weaver KL et al (2020) Evaluation of appropriateness and cost savings of pharmacist-driven palivizumab ordering. J Pediatr Pharmacol Ther 25(7):636\u2013641","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"24","key":"3163_CR14","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2146\/ajhp150989","volume":"73","author":"SE Rostas","year":"2016","unstructured":"Rostas SE, McPherson C (2016) Pharmacist-driven respiratory syncytial virus prophylaxis stewardship service in a neonatal intensive care unit. Am J Health Syst Pharm 73(24):2089\u20132094","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"3163_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2146\/ajhp150499","volume":"73","author":"TN Zembles","year":"2016","unstructured":"Zembles TN et al (2016) Implementation of American Academy of Pediatrics guidelines for palivizumab prophylaxis in a pediatric hospital. Am J Health Syst Pharm 73(6):405\u2013408","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"3163_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S1047951120001092","volume":"30","author":"K Sel","year":"2020","unstructured":"Sel K et al (2020) Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis. Cardiol Young 30(6):818\u2013821","journal-title":"Cardiol Young"},{"issue":"1","key":"3163_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5144\/0256-4947.2021.31","volume":"41","author":"MHA Mohammed","year":"2021","unstructured":"Mohammed MHA et al (2021) Palivizumab prophylaxis against respiratory syncytial virus infection in patients younger than 2 years of age with congenital heart disease. Ann Saudi Med 41(1):31\u201335","journal-title":"Ann Saudi Med"},{"issue":"4","key":"3163_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/00224065.1984.11978921","volume":"16","author":"LS Nelson","year":"1984","unstructured":"Nelson LS (1984) The Shewhart control chart\u2014tests for special causes. J Qual Technol 16(4):237\u2013239","journal-title":"J Qual Technol"},{"key":"3163_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/PPA.S5696","volume":"3","author":"KS Anderson","year":"2009","unstructured":"Anderson KS et al (2009) Compliance with RSV prophylaxis: Global physicians\u2019 perspectives. Patient Prefer Adherence 3:195\u2013203","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"3163_CR20","doi-asserted-by":"publisher","first-page":"ooab087","DOI":"10.1093\/jamiaopen\/ooab087","volume":"4","author":"J Mrosak","year":"2021","unstructured":"Mrosak J et al (2021) The influence of integrating clinical practice guideline order bundles into a general admission order set on guideline adoption. JAMIA Open 4(4):ooab087","journal-title":"JAMIA Open"},{"key":"3163_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3216","volume":"370","author":"JL Kwan","year":"2020","unstructured":"Kwan JL et al (2020) Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ 370:m3216","journal-title":"BMJ"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03163-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:10:37Z","timestamp":1726053037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3163"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03163-4","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"type":"print","value":"0172-0643"},{"type":"electronic","value":"1432-1971"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This Quality Improvement Initiative was reviewed and determined to not meet the criteria for human subjects\u2019 research by the CHOP Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}